PACIRA BIOSCIENCES, INC. Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31)
PACIRA BIOSCIENCES, INC. (PCRX) had Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) of $100.00 thousand as of 2018-06-30, per its 10-K filed 2020-02-21.
Discontinued › Notes › Equity
us-gaap:CumulativeEffectOnRetainedEarningsNetOfTax1 · last filed 2020-02-21
- 2018-06-30: Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) $100.00K.
- 2017-01-01: Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) $300.00K.
| Period end | Cumulative Effect on Retained Earnings, Net of Tax (Deprecated 2020-01-31) |
|---|---|
| 2018-06-30 | $100.00K 10-K · filed 2020-02-21 |
| 2017-01-01 | $300.00K 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |